Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndr… Read More

Best Emergency Medicine Residency Programs: When future doctors set out on their path to becoming emergency care specialists, they frequently look for the most respected and beneficial train… Read More

SHELTON, CONNECTICUT — Monday, October 16, 2023 — NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal… Read More

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndr… Read More

Longeveron (NASDAQ: LGVN; LGVNR), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left hear… Read More

Toronto, Ontario--(Newsfile Corp. - October 2, 2023) - Medicus Pharma Ltd. (TSXV: MDCX) (formerly known as Interactive Capital Partners Corporation, "Medicus" or the "Company") is pleased to… Read More

Vir Biotechnology, Inc., announced that the first participant has been dosed in a new Phase I trial for an innovative HIV vaccine candidate, VIR-1388. The trial’s primary objective is… Read More

The central nervous system (CNS), consisting of the brain and spinal cord, is the command center of the human body. It assures cognitive, sensory, and motor functions through a dense network… Read More

Longeveron management will present at the 25th Annual H.C. Wainwright Global Investment Conference scheduled for September 11-13, 2023, in New York Wa’el Hashad, the company&r… Read More

Longeveron (NASDAQ: LGVN; LGVNR), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left hear… Read More

Longeveron (NASDAQ: LGVN; LGVNR), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left hear… Read More

MIAMI, August 29, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or “Company”), a clinical stage biotechnology company devel… Read More

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”), today announced the European Medicines Agency (EMA) has accepted for regulatory review the market… Read More

The Role of Controlled Clinical Trials in Drug Development… Read More

July 21, 2023 7:52 am ET RAHWAY, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside the United States a… Read More

Experienced Pharma Industry Clinical Operations Leader to Spearhead Development of Cellular Therapy Programs MIAMI, FL, July11, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (… Read More

What Is an ADME Study?… Read More

   Ipsen receives new FDA PDUFA date for investigational palovarotene for the treatment of people with FOP PDUFA date has been set for 16 August 2023 following the New Drug Appl… Read More

Tirzepatide Weight Loss Treatment Home… Read More

February 24, 2023 6:49 am ET RAHWAY, N.J. & MIAMI–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside the… Read More

Feb 14, 2023 22:50 IST New York [US], February 14 (AF): In preclinical models, an investigational contraceptive medication created by Weill Cornell Medicine researchers te… Read More

ContentOffset Nervousness And DespairPotential AdvantagesWhat Is The Potency Comparison Between Hhc And Delta 9 Thc?Botanic Wellness 3000mg Cbd Tincture Oil – 30mlHashish – A Psy… Read More

The holder of a Manufacturing Authorisation must manufacture medicinal products so as to ensure that they are fit for their intended use, comply with the requirements of the Marketing Author… Read More

TOKYO & MUNICH–(BUSINESS WIRE)–Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been recommended for appro… Read More

Bharat Book Bureau Provides the Trending Market Research Report on “Global Bispecific Antibody Market Opportunity, Drug Sales, Price & Clinical Trials Insight 2028” under the… Read More

The most valuable piece of any clinical trial is the patient. Patients willingly provide their time to researchers to help advance the field of medicine. However, research often comes with r… Read More

The transaction reflects a pre-money equity value of $400 million for AUM Biosciences -Transaction is expected to provide $69 million of gross proceeds (assuming no redemptions by Mountain C… Read More

Watertown News (https://www.watertownmanews.com/2022/09/01/watertown-company-acquired-by-major-pharmaceutical-firm/) The following announcement came from Novo Nordisk: Novo Nordis… Read More

Monkeypox, as soon as a comparatively obscure virus endemic to Africa, has bloomed into a world risk, infecting greater than 20,000 folks in 75 nations and forcing the World Well being… Read More

There are over 300 million people worldwide who are living with a rare disease and around 75 percent of rare diseases will affect pediatric patients. Pediatric rare disease clinical trials a… Read More

Today millions of investors use other apps like Robinhood to trade stock. They are in search of real and cheap penny stocks to buy for investing money. Have you heard about the term Penny st… Read More

"Bizarro World": Researcher Calls Out Censorship After Journal Pulls COVID-19 Vaccine Adverse Events Analysis Authored by Petr Svab via The Epoch Times (emphasis ours), Jessica… Read More

Cannabis has few medical benefits and there are many health consequences, a new study by Indian doctors states. While there has been a growing push to legalize cannabis in Ind… Read More